Menu

BeyondSPX has rebranded as EveryTicker. We now operate at everyticker.com, reflecting our coverage across nearly all U.S. tickers. BeyondSPX has rebranded as EveryTicker.

Amprius Technologies, Inc. (AMPX)

$15.99
+0.47 (3.06%)
Get curated updates for this stock by email. We filter for the most important fundamentals-focused developments and send only the key news to your inbox.

Data provided by IEX. Delayed 15 minutes.

Amprius Technologies: Silicon Anode Leadership Meets Defense-Driven Margin Inflection (NASDAQ:AMPX)

Executive Summary / Key Takeaways

  • Margin inflection signals commercial viability: Gross margin surged from -76% in 2024 to +11% in 2025, reaching 24% in Q4, proving that Amprius's silicon anode batteries have crossed from R&D curiosity to profitable product with pricing power in mission-critical applications.

  • Defense moat creates asymmetric upside: With 75% of Q3 revenue from aviation and a single defense customer representing $27 million (37% of total revenue), Amprius has built an NDAA-compliant supply chain that positions it as the default battery supplier for U.S. drone programs, creating sticky, high-value revenue streams.

  • Capital-efficient scaling de-risks execution: The contract manufacturing model provides access to 2 GWh of annual capacity while terminating the Colorado facility eliminated $110 million in lease obligations, enabling 71% revenue growth guidance for 2026 with under $10 million in CapEx.

  • Technology leadership commands premium pricing: 100% silicon nanode anodes delivering 450 Wh/kg—nearly double conventional batteries—powered Airbus's (EADSY) Zephyr to a 67-day stratospheric flight, demonstrating performance that justifies premium pricing and creates barriers to entry.

  • Concentration risk remains the central variable: Success hinges on converting defense pilot programs into long-term contracts while diversifying beyond the top customer; failure to secure multi-year agreements or manufacturing disruptions at key partners could derail the path to sustained profitability.

Setting the Scene: The Silicon Anode Revolution in Defense and Aerospace

Amprius Technologies, founded in 2008 from Stanford University silicon anode research, manufactures lithium-ion batteries that replace conventional graphite anodes with pure silicon nanowires. This matters because silicon stores nearly 10 times more lithium than graphite (3,400 mAh/g vs. 355 mAh/g), enabling energy densities up to 450 Wh/kg that are physically impossible with traditional chemistry. The company generates revenue by selling these high-performance cells to five end markets where weight and power are mission-critical: unmanned aerial vehicles, high-altitude pseudo-satellites, light electric vehicles, robotics, and electric vertical take-off aircraft.

The battery industry structure reveals why this positioning is valuable. Traditional lithium-ion giants like CATL (300750.SZ) and LG Energy Solution (373220.KS) optimize for cost in mass-market EVs, while emerging competitors like Enovix (ENVX) and QuantumScape (QS) chase consumer electronics or remain in development phases. Amprius occupies a narrow but defensible niche: defense and aerospace applications where performance is prioritized over price. This creates a natural moat because defense contractors cannot simply switch to cheaper alternatives without requalifying entire systems—a process that takes years and significant investment.

Industry trends amplify Amprius's opportunity. The electric aerospace market is estimated at $40-50 billion today, growing to $80 billion by decade's end, with batteries representing 10% of a drone's bill of materials. More importantly, U.S. executive orders promoting domestic drone production and NDAA regulations banning Chinese batteries from defense programs by 2028 create a regulatory tailwind that favors Amprius's emerging U.S. manufacturing footprint. The company's strategy—leverage contract manufacturing for scale while building NDAA-compliant domestic capacity—positions it to capture this forced substitution without the capital intensity of building greenfield factories.

Technology, Products, and Strategic Differentiation: Performance as Moat

Amprius's core technology is its 100% silicon nanowire anode , which management believes is the only known anode technology free of inactive additives. This is significant because conventional silicon anodes crack and fail during charging due to 400% volume expansion, but Amprius's nanowire architecture accommodates this mechanical stress while maintaining pure silicon's theoretical capacity. The result is a drop-in replacement for graphite anodes that works with standard lithium-ion manufacturing equipment, allowing contract manufacturers to produce SiCore cells without retooling entire factories—a critical advantage that accelerates scaling and reduces capital risk.

The product portfolio demonstrates deliberate market segmentation. SiCore Generation 2 cells, launched commercially in January 2024, deliver up to 450 Wh/kg for high-energy applications like HAPS , while high-power variants achieve 360 Wh/kg with 10C continuous discharge rates , enabling drone takeoff bursts and six-minute fast charging. This allows Amprius to tune cell chemistry for specific duty cycles rather than forcing customers to compromise with one-size-fits-all solutions. The 370 Wh/kg high-power pouch cell and 6,300 mAh cylindrical cell introduced in Q1 2025—winning "best in show" at the International Battery Seminar—show continuous innovation that widens the performance gap with competitors.

The technology's economic impact is visible in customer value propositions. When Nokia (NOK) Drone Networks adopted Amprius's balanced cells, they gained both burst power for takeoff and sustained energy for extended flight, ensuring safety-critical systems remained powered throughout missions. More dramatically, the Astero ISR drone flies 90% longer with SiCore batteries—nearly doubling flight time. In defense applications, 90% more loiter time translates directly into mission success, making performance the primary purchasing driver. This implies that Amprius can command premium pricing that sustains gross margins above 30% at scale, as management targets by decade's end.

Research and development efforts focus on extending cycle life while maintaining energy density. The company has shipped SiMaxx A-Sample EV cells achieving 360 Wh/kg and 1,200 W/kg power density, charging to 90% in 15 minutes—exceeding U.S. Advanced Battery Consortium 2025 targets. This opens the door to automotive applications where cycle life requirements are more stringent than aviation. Success would expand Amprius's addressable market from niche defense to mass-market EVs, fundamentally altering the growth trajectory and justifying the current 29.78x revenue multiple.

Loading interactive chart...

Financial Performance & Segment Dynamics: Evidence of a Working Model

Full-year 2025 revenue of $73 million represents a threefold increase over 2024, but the composition reveals the real story. Product sales surged to $71.6 million while customization services—a non-recurring revenue stream—fell to $0.3 million. This shows Amprius has transitioned from engineering prototypes to repeat product sales, a critical milestone for manufacturing businesses. The 335% year-over-year growth in Q2 product revenue, driven by over 600% increase in SiCore shipments in Q1 and over 450% in Q2, indicates accelerating adoption rather than one-time orders.

Loading interactive chart...

Gross margin improvement from -76% to +11% is the financial validation of the technology's commercial viability. The drivers are structural: favorable product mix as SiMaxx Generation 1 cells fell below 1% of revenue, higher volumes absorbing fixed costs, and SiCore's inherent profitability since launch. This proves Amprius can manufacture silicon anode batteries profitably at scale—a feat many competitors have yet to achieve. As revenue scales toward management's $125 million 2026 target, operating leverage should drive margins toward the 30% long-term target, turning cash flow positive and reducing dilution risk.

Loading interactive chart...

Segment dynamics show aviation dominating while diversification begins. Aviation generated 75% of Q3 revenue and over 90% in Q2, with the remainder from light electric vehicles. This concentration provides revenue predictability as defense budgets are typically more stable than consumer EV demand. However, the $21 million purchase order for Chinese LEVs secured in March 2026 demonstrates that the technology translates to cost-sensitive markets when performance justifies premium pricing. It implies that Amprius can penetrate multiple verticals without compromising margins, though LEV revenue will be lumpier due to model launch cycles.

The balance sheet provides strategic flexibility. With $90.5 million in cash and no debt as of December 31, 2025, Amprius has a 2.5-year runway at current burn rates. More importantly, the termination of the Colorado facility lease for a $20 million payment eliminated $110 million in future obligations while the $14.8 million DIU contract covers most 2026 CapEx. This shows management's discipline in abandoning capital-intensive plans when contract manufacturing proves superior, preserving cash for working capital rather than fixed assets.

Loading interactive chart...

Outlook, Management Guidance, and Execution Risk

Management's 2026 guidance of "at least $125 million" revenue and "at least $4 million" adjusted EBITDA represents 71% top-line growth with profitability. This implies the company will cross the Rule of 40 threshold in its first profitable year, a rare achievement for hardware companies. The guidance assumes geographic mix similar to Q2/Q3 2025, when over 80% of revenue came from outside the U.S., insulating the company from domestic tariff pressures and allowing focus on defense opportunities as they materialize.

The path to these targets relies on converting pilot programs into volume orders. Management notes that a Fortune 500 LEV customer will place volume orders in late 2026, while several eVTOL companies are testing cells with one leading player in a joint development program. The sales cycle is progressing from qualification to procurement, but the timing remains uncertain. While 2026 revenue could exceed $125 million if defense urgency accelerates, investors should wait for signed purchase orders before modeling significant upside.

Execution risk centers on manufacturing scaling. The contract manufacturing model provides access to 2 GWh of capacity, translating to roughly 50 million SA08 cells annually, enough to support over $1 billion in revenue if fully utilized. This removes the traditional battery company bottleneck of capacity constraints, but introduces dependency on partners like Berzelius and the newly announced Nanotech Energy. Amprius must maintain quality control and delivery performance across a distributed network; any partner failure could disrupt the $35 million UAS manufacturer contract that represents nearly half of current revenue.

Management's long-term targets—30% gross margins and 20% EBITDA margins by decade's end—assume leveraging $600 million of contracted capacity for mission-critical duty cycles. This frames the investment case around operational leverage rather than technology risk. The stock's 29.78x EV/Revenue multiple will likely compress as margins expand, provided volume growth materializes to absorb fixed costs and justify the premium valuation relative to peers like Solid Power (SLDP) at 21.59x.

Risks and Asymmetries: What Could Break the Thesis

Customer concentration poses the most immediate threat. One customer contributed $27.1 million in 2025 revenue (37% of total), and the top UAS manufacturer represented $35 million in Q3 orders. Losing a major defense program would create a revenue hole that cannot be quickly filled, given the 12-18 month qualification cycles for new customers. Investors must monitor contract renewal timing and competitive positioning; any hint of share loss would trigger a severe multiple re-rating despite technology leadership.

Third-party manufacturing dependencies create operational fragility. The exclusive supply agreement with Berzelius for silicon anode materials and reliance on Korean and Chinese contract manufacturers exposes Amprius to geopolitical disruptions and potential price increases. The NDAA requires all defense-related components to be sourced from compliant countries by 2028. While the technical work of qualifying all 11 internal SiCore components is complete, operational execution in securing multi-year supplier agreements remains a critical path item.

Geopolitical exposure is significant. Revenue from Ukraine surged to $33 million in 2025 from $6.4 million in 2024, reflecting defense urgency that could change with conflict resolution. This creates a revenue cliff risk if geopolitical tensions ease, and it exposes the company to supply chain disruptions from potential export controls on battery materials. The 2026 guidance may include a geopolitical premium that is not sustainable, requiring faster diversification into commercial markets to maintain growth.

Competition from well-capitalized incumbents remains a latent threat. While Amprius believes it has the only 100% silicon anode solution, companies like Samsung SDI (006400.KS) are developing silicon-blend chemistries that could achieve a significant portion of the performance at a lower cost. If these incremental improvements narrow the performance gap, defense customers might accept "good enough" solutions from established suppliers with proven scale. Amprius must continuously innovate to maintain its lead and pricing power.

Valuation Context: Pricing for Perfect Execution

At $16.00 per share, Amprius trades at 30.5 times trailing revenue and 29.8 times enterprise value to revenue, a premium to Solid Power's 21.6x but discount to Enovix's 35.6x. The multiple reflects investor confidence in the 71% revenue growth guidance and margin expansion story, leaving little room for execution missteps. The stock will likely be sensitive to quarterly results; any revenue shortfall or margin compression could lead to a correction, while beats may be rewarded with multiple expansion.

The balance sheet strength provides downside protection. With $90.5 million in cash, no debt, and quarterly cash burn of $3.5 million, Amprius has several years of runway at current consumption rates. This removes near-term dilution risk and gives management time to execute the commercialization strategy. Valuation is driven by operational metrics rather than survival concerns, a distinction from competitors like QuantumScape which have not yet reached commercial revenue.

Relative to peers, Amprius's 11.3% gross margin compares favorably to Solid Power's -15.3% and Enovix's 19.2%, though it remains below mature battery manufacturers. Amprius is earlier in the scaling curve but has demonstrated more operational progress than pre-revenue competitors. The valuation premium to Solid Power is supported by commercial traction, while the discount to Enovix reflects lower near-term margin visibility and higher customer concentration.

The path to valuation support requires delivering on the 2026 EBITDA target of $4 million, which would represent a 3.2% margin on $125 million revenue. Positive EBITDA would mark the transition from speculative growth stock to profitable industrial company. Q1 and Q2 2026 results will be critical; sustained positive gross margins and controlled OpEx growth will validate the thesis, while any reversal will expose the high multiple to compression.

Conclusion: A Battery Company at the Inflection Point

Amprius Technologies has converted breakthrough science into commercially viable, profitable products at scale. The margin inflection from -76% to +11% gross margin provides evidence that silicon nanowire anodes deliver sufficient value to command premium pricing in mission-critical applications. With defense customers representing the majority of revenue and NDAA compliance creating a protected market, Amprius has built a moat that extends beyond technology to include regulatory positioning and qualification-driven switching costs.

The investment thesis hinges on the durability of defense contract renewals and the pace of commercial diversification. The $35 million UAS order and $21 million LEV purchase order demonstrate that the technology translates across markets, but high customer concentration means that any share loss in the core defense segment would be difficult to replace quickly. Meanwhile, the contract manufacturing model de-risks scaling but introduces operational dependencies that require flawless execution.

Trading at 30 times revenue, the stock prices in successful delivery of the $125 million revenue and $4 million EBITDA guidance for 2026. While this leaves no margin for error, the balance sheet strength and demonstrated margin expansion provide evidence that the business model is working. For investors willing to accept the concentration risk, Amprius offers exposure to a technology that is genuinely disruptive, enabling capabilities in flight and power that were previously impossible. The company's ability to scale without stumbling will determine whether this inflection point leads to durable long-term growth.

Disclaimer: This report is for informational purposes only and does not constitute financial advice, investment advice, or any other type of advice. The information provided should not be relied upon for making investment decisions. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.